Andrea Casadei‐Gardini

机构：Vita-Salute San Raffaele University, IRCCS Ospedale San Raffaele, Istituti di Ricovero e Cura a Carattere Scientifico, Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele · ORCID：0000-0001-6289-7202

发表论文 387 篇 · 总被引 7625 次 · h-index 46

代表论文

• D-lactate and glycerol as potential biomarkers of sorafenib activity in hepatocellular carcinoma (2025 · Signal Transduction and Targeted Therapy · 被引 17)
• Durvalumab in Advanced Biliary Tract Cancer: Real‐World Data From a Large Cohort of Patients Across Multiple International Centers (2025 · Liver International · 被引 10)
• Comparative Effectiveness of Atezolizumab Plus Bevacizumab Versus Tremelimumab Plus Durvalumab in Patients with Hepatocellular Carcinoma (HCC) in a Real-World Setting (2025 · Targeted Oncology · 被引 8)
• Conversion Ability of Immunotherapy in Hepatocellular Carcinoma: Insights from the International Converse Study (2025 · Liver Cancer · 被引 5)
• THE CONCEPT OF “CONVERSE THERAPEUTIC HIERARCHY” FOR PATIENTS WITH HEPATOCELLULAR CARCINOMA (2025 · Liver Cancer · 被引 5)
• The impact of molecular alterations in patients with advanced biliary tract cancer receiving cisplatin, gemcitabine, and durvalumab: a large, real-life, worldwide population (2025 · JNCI Journal of the National Cancer Institute · 被引 4)